Experienced in Heart Failure with Preserved Ejection Fraction (HFpEF)

Neil P. Fam

St. Paul's Hospital
Vancouver, BC, CA 
Clinical Trials:Currently Recruiting for 1 Trial
Experienced in Heart Failure with Preserved Ejection Fraction (HFpEF)
St. Paul's Hospital
Vancouver, BC, CA 
OverviewLocationsClinical Research

Overview

Neil Fam practices in Vancouver, Canada. Mr. Fam is rated as an Experienced expert by MediFind in the treatment of Heart Failure with Preserved Ejection Fraction (HFpEF). His top areas of expertise are Tricuspid Regurgitation, Mitral Valve Regurgitation, Heart Failure, Transcatheter Aortic Valve Replacement (TAVR), and Lithotripsy.

His clinical research consists of co-authoring 170 peer reviewed articles and participating in 8 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 2 articles in the study of Heart Failure with Preserved Ejection Fraction (HFpEF).

Gender
Male

Locations

St. Paul's Hospital
Vancouver, BC, Canada

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

8 Clinical Trials

Clinical Trial to Evaluate the Safety and Effectiveness of Using the Tendyne Transcatheter Mitral Valve System for the Treatment of Symptomatic Mitral Regurgitation
Clinical Trial to Evaluate the Safety and Effectiveness of Using the Tendyne Transcatheter Mitral Valve System for the Treatment of Symptomatic Mitral Regurgitation
Enrollment Status: Recruiting
Publish Date: January 31, 2025
Intervention Type: Device
Study Phase: Not Applicable
Edwards EVOQUE Tricuspid Valve Replacement: Investigation of Safety and Clinical Efficacy After Replacement of Tricuspid Valve With Transcatheter Device
Edwards EVOQUE Tricuspid Valve Replacement: Investigation of Safety and Clinical Efficacy After Replacement of Tricuspid Valve With Transcatheter Device
Enrollment Status: Active_not_recruiting
Publish Date: August 15, 2025
Intervention Type: Device
Study Phase: Not Applicable
A Post-Market Study Assessment of the Safety and Performance of the MitraClip G4 System
A Post-Market Study Assessment of the Safety and Performance of the MitraClip G4 System
Enrollment Status: Active_not_recruiting
Publish Date: July 11, 2025
Intervention Type: Device
The CLASP Study Edwards PASCAL TrAnScatheter Mitral Valve RePair System Study
The CLASP Study Edwards PASCAL TrAnScatheter Mitral Valve RePair System Study
Enrollment Status: Active_not_recruiting
Publish Date: February 14, 2025
Intervention Type: Device
Study Phase: Not Applicable
Clinical Trial to Evaluate Cardiovascular Outcomes In Patients Treated With the Tricuspid Valve Repair System Pivotal
Clinical Trial to Evaluate Cardiovascular Outcomes In Patients Treated With the Tricuspid Valve Repair System Pivotal
Enrollment Status: Active_not_recruiting
Publish Date: December 19, 2024
Intervention Type: Device
Study Phase: Not Applicable
Edwards EVOQUE Eos Mitral Valve Replacement: Investigation of Safety and Performance After Mitral Valve Replacement With Transcatheter Device (MISCEND)
Edwards EVOQUE Eos Mitral Valve Replacement: Investigation of Safety and Performance After Mitral Valve Replacement With Transcatheter Device (MISCEND)
Enrollment Status: Active_not_recruiting
Publish Date: November 27, 2024
Intervention Type: Device
Study Phase: Not Applicable
AMPLATZER™ LAA Occluder Post Approval Study
AMPLATZER™ LAA Occluder Post Approval Study
Enrollment Status: Completed
Publish Date: March 29, 2024
Intervention Type: Device
The RELIEF Trial: REduction or eLimination of mItral rEgurgitation in Degenerative or Functional Mitral Regurgitation With the CardiAQ-Edwards™ Transcatheter Mitral Valve
The RELIEF Trial: REduction or eLimination of mItral rEgurgitation in Degenerative or Functional Mitral Regurgitation With the CardiAQ-Edwards™ Transcatheter Mitral Valve
Enrollment Status: Withdrawn
Publish Date: January 09, 2018
Intervention Type: Device
Study Phase: Phase 1/Phase 2
View 7 Less Clinical Trials

170 Total Publications

Transcatheter tricuspid valve replacement using the LuX-Valve Plus system: 1-year compassionate use outcomes.
Transcatheter tricuspid valve replacement using the LuX-Valve Plus system: 1-year compassionate use outcomes.
Journal: European journal of heart failure
Published: June 20, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Fam's expertise for a condition
ConditionClose
    View All 18 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile